Effects of Nifedipine on Carotid and Femoral Arterial Wall Thickness in Previously Untreated Hypertensive Patients

References

• O'Leary DH, Polak JF, Kronmal RA, etal. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23: 1752–60.
   Google Scholar
• Mowbray PI, Lee AJ, Fowkes GR, Allan PL. Cardiovascular risk factors for early carotid atherosclerosis in the general population: the Edinburgh Artery Study. J Cardiovasc Risk 1997; 4: 357–62.
   PubMedGoogle Scholar
• Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160: 2297–303.
   Google Scholar
• Zanchetti A, Bond MG, Hennig M, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16: 949–61.
   PubMed Web of Science ®Google Scholar
• Bots ML, Breslau PJ, Briet E, et al. Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension 1992; 19: 717–20.
   PubMed Web of Science ®Google Scholar
• Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Com-munities (ARIC) Study. Stroke 1995; 26: 386–91.
   Google Scholar
• Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edin-burgh Artery Study. Stroke 1997; 28: 348–53.
   Google Scholar
• Blankenhorn DH, Selzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993; 88: 20–8.
   Google Scholar
• Zanchetti A. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. J Hypertens Suppl 1996; 14: S77–80.
   Google Scholar
• Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin Exp Hypertens 1992; A14: 307–31.
   Google Scholar
• Rafflenbeul W. Anti-atherosclerotic properties of nifedipine. Benefit of early intervention to prevent cardiovascular complications. Cardiology 1997; 88 Suppl 3: 52–5.
   Google Scholar
• Lichtlen PR, Hugenholtz PG, Rafflenbeul W, et al. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators. Lancet 1990; 335: 1109–13.
   Google Scholar
• Hansson L, Zanchetti A. The antiatherosclerotic effect of calcium antagonists in man - what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. Blood Press 1995; 4: 133–6.
   PubMedGoogle Scholar
• Zanchetti A, Rosei EA, Dal Palu C, et al. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hyper-tens 1998; 16: 1667–76.
   Google Scholar
• Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilorizide on the progression of early carotid wall changes. Circulation 2001; 103: 2949–54.
   PubMed Web of Science ®Google Scholar
• de Groot E, Zwinderman AH, van der Steen AF, et al. Variance components analysis of carotid and femoral intima-media thickness measurements. REGRESS Study Group, Interuniversity Cardiology Institute of The Nether-lands, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Ultrasound Med Biol 1998; 24: 825–32.
   Google Scholar
• Selzer RH, Hodis HN, Kwong FH, et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994; 111: 1–11.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–8.
   PubMed Web of Science ®Google Scholar
• de Groot E, Ackerstaff RG, Bom N, etal. Power calculations describing the relationship between the number of measure-ments and the intimal detectable differences in intimal thickness in repeated high resolution B-mode ultrasound scans of the carotid artery walls. Eur Heart J 1993; 15: P504 (Abstract)..
   Google Scholar
• Salonen R, Haapanen A, Salonen JT. Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol 1991; 17: 225–30.
   Google Scholar
• Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke 1997; 28: 665–71.
   PubMed Web of Science ®Google Scholar
• Pitt B, Byington RP, Furberg C, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503–10.
   PubMed Web of Science ®Google Scholar
• Stary HC, Blankenhorn DH, Chandler AB, etal. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler Thromb 1992; 12: 120–34.
   PubMed Web of Science ®Google Scholar
• Boutouyrie P. Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000; 101: 2601–6.
   PubMedGoogle Scholar
• Verhaar MC, Honing ML, van Dam T, et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res 1999; 42: 752–60.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 1996; 14: 1247–55.
   PubMed Web of Science ®Google Scholar
• Berkels R, Egink G, Marsen TA, etal. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 2001; 37: 240–5.
   PubMed Web of Science ®Google Scholar
• Neutel JM. Low-dose antihypertensive combination ther-apy: its rationale and role in cardiovascular risk manage-ment. Am J Hypertens 1999; 12: 73–9S.
   PubMedGoogle Scholar
• Joint National Committee on Prevention, Detection, Evalu-ation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413–46.
   PubMedGoogle Scholar
• Guidelines Subcommittee. 1999 World Health Organiza-tion-International Society of Hypertension. Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–83.
   Google Scholar
• Beltman FW, Heesen WF, Smit AJ, et al. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension. Blood Press 1998; 7: 109–17.
   PubMedGoogle Scholar
• Terpstra WF, May IF, Smit AJ, et al. Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hyperten-sive patients: the ELVERA trial. J Hypertens 2001; 19: 303–9.
   PubMed Web of Science ®Google Scholar